INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma	Ovarian Clear Cell Carcinoma	Recruiting	Phase 3	2026-05-18		NCT07002346

27 results · Page 1 of 2

Swipe the table sideways for more columns.

Organizations	Linked trials
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center	23
Chinese Academy of Medical Sciences	36
First Affiliated Hospital of Zhejiang University	201
First Affiliated Hospital, Sun Yat-Sen University	113
Fudan University	653
Henan Cancer Hospital	147
Henan Provincial People's Hospital	95
Hubei Cancer Hospital	29
Jiangsu Cancer Institute & Hospital	45
Peking Union Medical College Hospital	417
Peking University Cancer Hospital & Institute	189
Peking University People's Hospital	269
Renmin Hospital of Wuhan University	73
Second Affiliated Hospital, Sun Yat-Sen University	5
Second Affiliated Hospital, Zhejiang University, School of Medicine	561
Shanghai First Maternity and Infant Hospital	18
Sir Run Run Shaw Hospital	117
Sun Yat-Sen University Cancer Center	74
The First Affiliated Hospital of Zhengzhou University	203
The International Peace Maternity & Child Health Hospital of China welfare institute	1
Third Affiliated Hospital of Zhengzhou University	6
Tongji Hospital	276
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	319
Women's Hospital School Of Medicine Zhejiang University	60
Wuhan Central Hospital	22

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Tongji Hospital	Wuhan	China	13

Clinical trials